[1]
2025. Predictors of persistent high disease activity after methotrexate treatment in rheumatoid arthritis patients. Universa Medicina. 44, 2 (Jul. 2025), 141–151. DOI:https://doi.org/10.18051/UnivMed.2025.v44.141-151.